Together, available data indicate that AngII/AT1R signaling impairs tumor blood supply through multiple mechanisms, such as desmoplasia-mediated vessel compression, VEGF-induced vessel leakiness and abnormal morphology, and AngIImediated vasoconstriction of host vessels. This evidence concerns the gene VEGFA and neoplasm.